Over the trailing 12 months, SEPN insiders sold $76.05 million worth of shares (1.8Mn shares) in open-market trades, with no open-market purchases.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Rock Ventures V, L.P. Third | TenPercentOwner | 6,068,391 | 0 | 6,068,391 | 49.4% | 14 Aug, 2026 |
| 2 | Rock Ventures Vi, L.P. Third | TenPercentOwner | 4,211,659 | 0 | 4,211,659 | 34.3% | 26 Feb, 2025 |
| 3 | Jeffrey Finer | Ceo And President | 826,907 | 0 | 826,907 | 6.7% | 04 Apr, 2025 |
| 4 | Capital Management, L.P. Ra | Director, TenPercentOwner | 0 | 725,443 | 725,443 | 5.9% | 14 Aug, 2026 |
| 5 | Elizabeth Bhatt | President And Coo | 174,209 | 0 | 174,209 | 1.4% | 13 Aug, 2026 |
| 6 | Alan Ezekowitz | Director | 117,420 | 0 | 117,420 | 1.0% | 10 Mar, 2025 |
| 7 | Daniel D. Long | Svp, Drug Discovery | 96,412 | 0 | 96,412 | 0.8% | 03 Sep, 2026 |
| 8 | Gil M Labrucherie | Chief Financial Officer | 0 | 40,000 | 40,000 | 0.3% | 27 Feb, 2025 |
| 9 | Uwe Klein | Svp, Biological Sciences | 23,008 | 0 | 23,008 | 0.2% | 19 Aug, 2025 |
| 10 | Samira Shaikhly | Chief People Officer | 793 | 0 | 793 | 0.0% | 30 Jun, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 08 Sep, 2026 | Rajiv Patni | Chief Medical Officer | Acquired A | 275,000 | $0.00 | $0 | 275,000 | Direct |
| 01 Sep, 2026 | Daniel D. Long | Svp, Drug Discovery | Acquired M | 3,333 | $2.76 | $9.20K | 99,745 | Direct |
| 01 Sep, 2026 | Daniel D. Long | Svp, Drug Discovery | Disposed S | 3,333 | $37.83 | $126.08K | 96,412 | Direct |
| 01 Sep, 2026 | Daniel D. Long | Svp, Drug Discovery | Disposed M | 3,333 | $0.00 | $0 | 9,085 | Direct |
| 12 Aug, 2026 | Rock Ventures V, L.P. Third | TenPercentOwner | Acquired S | 147,059 | $50.27 | $7.39Mn | 6,068,532 | Direct |
| 12 Aug, 2026 | Capital Management, L.P. Ra | Director, TenPercentOwner | Disposed S | 746,500 | $42.50 | $31.73Mn | 4,777,415 | Indirect |
| 12 Aug, 2026 | Rock Ventures V, L.P. Third | TenPercentOwner | Acquired S | 141 | $51.08 | $7.20K | 6,068,391 | Direct |
| 12 Aug, 2026 | Capital Management, L.P. Ra | Director, TenPercentOwner | Disposed S | 746,500 | $42.50 | $31.73Mn | 725,443 | Indirect |
| 11 Aug, 2026 | Elizabeth Bhatt | President And Coo | Acquired M | 18,681 | $6.81 | $127.22K | 192,890 | Direct |
| 11 Aug, 2026 | Elizabeth Bhatt | President And Coo | Acquired M | 6,319 | $2.76 | $17.44K | 199,209 | Direct |
| 11 Aug, 2026 | Elizabeth Bhatt | President And Coo | Disposed S | 25,000 | $44.00 | $1.10Mn | 174,209 | Direct |
| 11 Aug, 2026 | Elizabeth Bhatt | President And Coo | Disposed M | 18,681 | $0.00 | $0 | 62,230 | Direct |
| 11 Aug, 2026 | Elizabeth Bhatt | President And Coo | Disposed M | 6,319 | $0.00 | $0 | 82,332 | Direct |
| 03 Aug, 2026 | Daniel D. Long | Svp, Drug Discovery | Acquired M | 1,816 | $2.76 | $5.01K | 98,228 | Direct |
| 03 Aug, 2026 | Daniel D. Long | Svp, Drug Discovery | Acquired M | 1,518 | $2.76 | $4.19K | 99,746 | Direct |
| 03 Aug, 2026 | Daniel D. Long | Svp, Drug Discovery | Disposed S | 1,000 | $33.98 | $33.98K | 98,746 | Direct |
| 03 Aug, 2026 | Daniel D. Long | Svp, Drug Discovery | Disposed S | 2,334 | $34.68 | $80.94K | 96,412 | Direct |
| 03 Aug, 2026 | Daniel D. Long | Svp, Drug Discovery | Disposed M | 1,816 | $0.00 | $0 | 5,227 | Direct |
| 03 Aug, 2026 | Daniel D. Long | Svp, Drug Discovery | Disposed M | 1,518 | $0.00 | $0 | 12,418 | Direct |
| 15 Jul, 2026 | Elizabeth Bhatt | President And Coo | Acquired M | 4,000 | $6.81 | $27.24K | 178,209 | Direct |